U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727317) titled 'Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants With Advanced Solid Tumors' on July 15.
Brief Summary: This is a prospective, single-center, open-label clinical study comparing the imaging performance of INR202 PET/CT versus 18F-FDG PET/CT in participants with advanced solid tumors.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Intervention:
DIAGNOSTIC_TEST: INR202+FDG
single administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai Zhongshan Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....